prof. dr. E.P. (Eugène) van Puijenbroek

Professor of Pharmacovigilance

prof. dr. E.P. (Eugène) van Puijenbroek
Telephone:
Netherlands Pharmacovigilance Centre Lareb:
+31 73 646 9700 (Secretariaat)
e.vanpuijenbroek lareb.nl
E-mail:
e.p.van.puijenbroek rug.nl

Research

Postal address:
A Deusinglaan1
9713 AV
Groningen
Netherlands
Phone: +31 50 363 7576
  1. 2020
  2. Flinterman, L. E., Kuiper, J. G., Korevaar, J. C., van Dijk, L., Hek, K., Houben, E., ... Fliers, E. (2020). Impact of a Forced Dose-Equivalent Levothyroxine Brand Switch on Plasma Thyrotropin: A Cohort Study. Thyroid. https://doi.org/10.1089/thy.2019.0414
  3. Ghalandari, N., Dolhain, R. J. E. M., Hazes, J. M. W., Siezen, C. L. E., van der Laan, J. W., Crijns, H. J., ... van der Woude, C. J. (2020). The pre- and post-authorisation data published by the European Medicines Agency on the use of Biologics during pregnancy and lactation. British Journal of Clinical Pharmacology, 86(3), 580-590. https://doi.org/10.1111/bcp.14145
  4. 2019
  5. Sultana, J., Moretti, U., Addis, A., Caduff, P., Capuano, A., Kant, A., ... Leone, R. (2019). Workshop on the Italian Pharmacovigilance System in the International Context: Critical Issues and Perspectives. Drug Safety, 42(5), 683–687. https://doi.org/10.1007/s40264-018-0768-6
  6. van Gelder, M. M. H. J., de Jong, L. A. A., te Winkel, B., Olyslager, E. J. H., Vorstenbosch, S., van Puijenbroek, E. P., ... Roeleveld, N. (2019). Assessment of medication use during pregnancy by Web-based questionnaires, pharmacy records and serum screening. Reproductive Toxicology, 84, 93-97. https://doi.org/10.1016/j.reprotox.2019.01.002
  7. Vorstenbosch, S., te Winkel, B., van Gelder, M. M. H. J., Kant, A., Roeleveld, N., & van Puijenbroek, E. (2019). Aim and Design of pREGnant, the Dutch Pregnancy Drug Register. Drug Safety, 42(1), 1-12. https://doi.org/10.1007/s40264-018-0722-7
  8. 2018
  9. van Puijenbroek, E. (2018). Congenital malformations. In A. Bate (Ed.), Evidence-Based Pharmacovigilance: Clinical and Quantiative Aspects (pp. 1-16). (Methods in Pharmacology and Toxicology). New York, NY: Humana Press. https://doi.org/10.1007/978-1-4939-8818-1_1
  10. Hilgersom, W., Van Hunsel, F., & Van Puijenbroek, E. (2018). A systematic step-by-step approach to vaccine signal detection. 1247. Abstract from 18th ISoP Annual Meeting “Pharmacovigilance without borders” , Geneva, Switzerland. https://doi.org/10.1007/s40264-018-0719-2
  11. Van Balveren, L., Van Hunsel, F., & Van Puijenbroek, E. (2018). Comparison of reported adverse events of premature and term born infants following childhood vaccinations in the Netherlands. 1198. Abstract from 18th ISoP Annual Meeting “Pharmacovigilance without borders” Geneva, Switzerland, 11–14 November, 2018, Geneva, Switzerland. https://doi.org/10.1007/s40264-018-0719-2
  12. Hilgersom, W., Van Hunsel, F., & Van Puijenbroek, E. (2018). Importance of background information of the national immunization program for children in vaccine signal detection. 1246. Abstract from 18th ISoP Annual Meeting “Pharmacovigilance without borders” Geneva, Switzerland, 11–14 November, 2018, Geneva, Switzerland. https://doi.org/10.1007/s40264-018-0719-2
  13. Rolfes, L., Hek, K., Verheij, R., Van Dijk, L., & Van Puijenbroek, E. (2018). Monitor the benefit and risk of medicines in primary care; Building a bridge between daily practice and research. 1147. Abstract from 18th ISoP Annual Meeting “Pharmacovigilance without borders” Geneva, Switzerland, 11–14 November, 2018, Geneva, Switzerland. https://doi.org/10.1007/s40264-018-0719-2
  14. van Gelder, M. M. H. J., de Jong, L. A. A., te Winkel, B., Olyslager, E. J. H., Vorstenbosch, S., van Puijenbroek, E. P., & Roeleveld, N. (2018). Assessment of medication use during pregnancy by web-based questionnaires, pharmacy records, and biological monitoring in blood. Pharmacoepidemiology and Drug Safety, 27, 55-55.
Previous 1 2 3 4 5 6 Next

ID: 482088